title: Airway extravasation induced by increasing airway temperature in ovalbumin-sensitized rats.
abstract: This study was carried out to determine whether hyperventilation of humidified warm air (HWA) induced airway extravasation in ovalbumin (Ova)-sensitized rats. Our results showed: (1) After isocapnic hyperventilation with HWA for 2 min, tracheal temperature (Ttr) was increased to 40.3°C, and the Evans blue contents in major airways and lung tissue were elevated to 651% and 707%, respectively, of that after hyperventilation with humidified room air in Ova-sensitized rats; this striking effect of HWA was absent in control rats. (2) The HWA-induced increase in Evans blue content in sensitized rats was completely prevented by a pretreatment with either L-732138, a selective antagonist of neurokinin type 1 (NK-1) receptor, or formoterol, a selective agonist of β2 adrenoceptor. This study demonstrated that an increase in airway temperature induced protein extravasation in the major airways and lung tissue of sensitized rats, and an activation of the NK-1 receptor by tachykinins released from bronchopulmonary C-fiber nerve endings was primarily responsible.
authors: Department of Physiology, University of Kentucky Medical Center, 800 Rose St., MS511A, Lexington, KY 40536-0298, USA.
authors: Chun-Chun
authors: CC
authors: Hsu
authors: Department of Physiology, University of Kentucky Medical Center, 800 Rose St., MS511A, Lexington, KY 40536-0298, USA.
authors: Reyno J
authors: RJ
authors: Tapia
authors: Department of Physiology, University of Kentucky Medical Center, 800 Rose St., MS511A, Lexington, KY 40536-0298, USA. Electronic address: lylee@uky.edu.
authors: Lu-Yuan
authors: LY
authors: Lee
mesh_terms: D000403:Airway Resistance / Q000187:drug effects; D000704:Analysis of Variance; D000818:Animals; D001549:Benzamides / Q000494:pharmacology; D001992:Bronchoalveolar Lavage Fluid; D001993:Bronchodilator Agents / Q000627:therapeutic use; D005070:Evans Blue / Q000378:metabolism; D000068759:Formoterol Fumarate / Q000627:therapeutic use; D006358:Hot Temperature / Q000009:adverse effects*; D008297:Male; D010047:Ovalbumin / Q000633:toxicity*; D010880:Piperidines / Q000494:pharmacology; D051381:Rats; D012130:Respiratory Hypersensitivity / Q000139:chemically induced* / Q000188:drug therapy / Q000503:physiopathology*; D014132:Trachea / Q000503:physiopathology*; D014364:Tryptophan / Q000031:analogs & derivatives / Q000494:pharmacology
chemical_list: D001549:Benzamides; D001993:Bronchodilator Agents; D010880:Piperidines; C086089:3,5-bis(trifluoromethyl)benzyl N-acetyltryptophan; D005070:Evans Blue; C073839:SR 48968; D014364:Tryptophan; D010047:Ovalbumin; D000068759:Formoterol Fumarate
keywords: Asthma; Bronchoconstriction; C-fiber; Tachykinins; Vagus